152 related articles for article (PubMed ID: 19401542)
1. Ninth Biannual Report of the Cochrane Haematological Malignancies Group--focus on hematopoietic growth factors.
Skoetz N; Weingart O; Monsef I; Bauer K; Brillant C; Herbst C; Kluge S; Engert A;
J Natl Cancer Inst; 2009 May; 101(9):E1. PubMed ID: 19401542
[No Abstract] [Full Text] [Related]
2. Epoetin versus darbepoetin conundrum compromise.
Bleyer A
J Clin Oncol; 2006 Sep; 24(25):e46. PubMed ID: 16943519
[No Abstract] [Full Text] [Related]
3. Erythropoietin: high profile, high scrutiny.
Crawford J
J Clin Oncol; 2007 Mar; 25(9):1021-3. PubMed ID: 17312331
[No Abstract] [Full Text] [Related]
4. The therapeutic use of hematopoietic growth factors.
Costa JJ
J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):1-6. PubMed ID: 9449493
[No Abstract] [Full Text] [Related]
5. Clinical use of hematopoietic growth factors.
Löwenberg B; Dale DC; Sheridan WP
Rev Invest Clin; 1994 Apr; Suppl():33-40. PubMed ID: 7886306
[No Abstract] [Full Text] [Related]
6. Third biannual report of the Cochrane Haematological Malignancies Group.
Kober T; Skoetz N; Trelle S; Bohlius J; Engert A;
J Natl Cancer Inst; 2005 Aug; 97(16):E2. PubMed ID: 16106014
[No Abstract] [Full Text] [Related]
7. Eighth biannual report of the Cochrane Haematological Malignancies Group--focus on chronic lymphatic leukemia.
Herbst C; Monsef I; Skötz N; Engert A;
J Natl Cancer Inst; 2008 Aug; 100(15):E1. PubMed ID: 18664654
[No Abstract] [Full Text] [Related]
8. Sixth biannual report of the Cochrane Haematological Malignancies Group--focus on non-Hodgkin lymphoma.
Weingart O; Rehan FA; Schulz H; Naumann F; Knauel I; Bohlius CB; Engert A
J Natl Cancer Inst; 2007 Sep; 99(17):E1. PubMed ID: 17728205
[No Abstract] [Full Text] [Related]
9. Biannual report of the Cochrane Haematological Malignancies Group.
Trelle S; Higgins G; Kober T; Engert A
J Natl Cancer Inst; 2004 Aug; 96(15):E2. PubMed ID: 15292394
[No Abstract] [Full Text] [Related]
10. Fourteenth biannual report of the Cochrane Haematological Malignancies Group--focus on autologous stem cell transplantation in hematological malignancies.
Rancea M; Skoetz N; Monsef I; Hübel K; Engert A; Bauer K
J Natl Cancer Inst; 2012 Jul; 104(14):NP. PubMed ID: 22825560
[No Abstract] [Full Text] [Related]
11. Treatment of cancer-related anemia with epoetin alfa: a review.
Ferrario E; Ferrari L; Bidoli P; De Candis D; Del Vecchio M; De Dosso S; Buzzoni R; Bajetta E
Cancer Treat Rev; 2004 Oct; 30(6):563-75. PubMed ID: 15325036
[TBL] [Abstract][Full Text] [Related]
12. [Clinical use of hematopoietic growth factors].
Robak T
Pol Tyg Lek; 1992 Apr 20-27; 47(16-17):365-8. PubMed ID: 1279638
[No Abstract] [Full Text] [Related]
13. Epoetin alfa and chemotherapy: a summary of two studies on preventive and maintenance use.
J Support Oncol; 2003; 1(2):104, 120. PubMed ID: 15352653
[No Abstract] [Full Text] [Related]
14. [Use of hematopoietic growth factors in oncology].
Delmer A; Zittoun R
Bull Cancer; 1991; 78(2):115-31. PubMed ID: 2036483
[TBL] [Abstract][Full Text] [Related]
15. Can erythropoietin therapy improve survival?
Glaspy J; Dunst J
Oncology; 2004; 67 Suppl 1():5-11. PubMed ID: 15486447
[TBL] [Abstract][Full Text] [Related]
16. [Hematopoietic growth factors in oncology and hematology. Recommendations for more cost-efficient use].
Paul C; Hast R
Lakartidningen; 2000 Jun; 97(23):2862-6. PubMed ID: 10885223
[No Abstract] [Full Text] [Related]
17. Prophylactic use of myelopoietic growth factors in children after myelosuppressive and myeloablative therapy.
Satwani P; Bessmertny O; Morris E; Cairo MS
Curr Hematol Rep; 2003 Nov; 2(6):480-90. PubMed ID: 14561392
[TBL] [Abstract][Full Text] [Related]
18. [Erythropoietin is a novel therapeutic option in the treatment of anemia caused by small cell lung cancer].
Tamási L; Bohács A; Wollák A; Magyar P
Magy Onkol; 2006; 50(3):243-6. PubMed ID: 17099785
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic growth factors as supportive therapy for cancer- and chemotherapy-induced conditions.
Symann M
Curr Opin Oncol; 1991 Aug; 3(4):648-55. PubMed ID: 1932223
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic growth factors in cancer chemotherapy.
Lieschke GJ; Foote M; Morstyn G
Cancer Chemother Biol Response Modif; 1997; 17():363-89. PubMed ID: 9551221
[No Abstract] [Full Text] [Related]
[Next] [New Search]
